201920182017201620152014 December 19, 2016 Summary ToggleSpero Therapeutics Initiates First Clinical Study of Lead Potentiator Candidate for the Treatment of Multidrug Resistant Gram-Negative Infections November 10, 2016 Summary ToggleSpero Therapeutics to Present at Two Upcoming November Conferences October 18, 2016 Summary ToggleSpero Therapeutics Announces $1.65 Million Award from Department of Defense to Develop Novel Combination Therapy for Multidrug-Resistant, Gram-Negative Pathogens September 06, 2016 Summary ToggleSpero Therapeutics to Participate in Citi’s 11th Annual Biotech Conference September 06, 2016 Summary ToggleSpero Therapeutics Joins ENABLE (European Gram-negative Antibacterial Engine) Project to Combat Antibiotic-Resistant Bacteria August 15, 2016 Summary ToggleSpero Therapeutics to Present at the 2016 Wedbush PacGrow Healthcare Conference June 20, 2016 Summary ToggleSpero Therapeutics Unveils Data on Lead Potentiator Candidate for the Treatment of Multidrug Resistant Gram-Negative Infections at ASM Microbe 2016 June 08, 2016 Summary ToggleSpero Therapeutics to Unveil Data on Potentiator Platform at ASM Microbe 2016 April 05, 2016 Summary ToggleSpero Therapeutics Hires Cristina Larkin as Chief Commercial Officer March 02, 2016 Summary ToggleSpero Therapeutics Hires Cristina Larkin as Chief Commercial Officer Pagination Current page 1 Page 2 Next page Next Last page Last
